ESC Professional Premium Access

One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk

Congress Presentation

About the speaker

Doctor Carlo Andrea Pivato

Humanitas Research Hospital, Milan (Italy)
0 follower

6 more presentations in this session

Beta-blockers after STEMI: prognostic impact and predictors of adherence, results from the real-world FAST-STEMI registry

Speaker: Doctor E. Ravetti (Turin, IT)

Thumbnail

Changes of hospital-level variation in use of optimal medical treatment for long-term follow-up from a multi-level methodological approach

Speaker: Doctor H. Kwak (Daegu, KR)

Thumbnail

Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry

Speaker: Professor L. Rallidis (Athens, GR)

Thumbnail

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

Speaker: Professor R. Marcucci (Florence, IT)

Thumbnail

Ticagrelor versus Clopidogrel in diabetes patients afflicted with acute coronary syndrome stratified by renal function

Speaker: Doctor T. Wang (Taipei, TW)

Thumbnail

Access the full session

Pharmacotherapy of acute coronary syndromes in clinical practice

Speakers: Doctor C. Pivato, Doctor E. Ravetti, Doctor H. Kwak, Professor L. Rallidis, Professor R. Marcucci...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations